| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 04/10/2008 | WO2008041088A2 N-hydroxy benzamides with antitumor activity |
| 04/10/2008 | WO2008040979A1 Arginine derivatives with np-i antagonistic activity |
| 04/10/2008 | WO2008008701B1 Substituted cyclopentane derivatives as therapeutic agents |
| 04/10/2008 | US20080086011 Processes for the preparation of N-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)amino[sulfonyl}-2-thiophenecarboxamide |
| 04/10/2008 | US20080085928 such as N,N'-[hexane-1,6-diylbis(iminocarbonyl)]bis(3-chlorobenzenesulfonamide), used as Fructose-1,6-bisphosphatase inhibitors; metabolic disorders such as diabetes |
| 04/10/2008 | US20080085927 Peroxisome proliferator activated receptors; dyslipidemia; anticholesterol agents; antidiabetic agents; cardiovascular disorders; gastrointestinal disorders; {4-[2-ethoxy-3-(4-trifluoromethyl-phenoxy)-propoxy]-2-methyl-phenoxy}-acetic acid |
| 04/10/2008 | US20080085924 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials |
| 04/10/2008 | US20080085900 Sulfonylguanidine compounds and pharmaceutical uses thereof |
| 04/10/2008 | US20080085894 Alpha-(n-sulfonamido)acetamide derivatives as beta-amyloid inhibitors |
| 04/10/2008 | US20080085893 N-Hydroxy (2S)-2-hydroxy phenyl or heteroaryl sulfonamide derivatives; for example, N-Hydroxy (2S)-2-hydroxy-3-{N-[4-(4- chlorophenoxy)phenyl], N- methanesulfonylamino}propionamide; for treating disorders related to matrix metalloproteases, particularly useful for treating strokes; |
| 04/10/2008 | US20080085891 Asthma and allergic inflammation modulators |
| 04/10/2008 | US20080085244 comparing levels with untreated ovariectomized animal determining amount of an estrogen to reduce amyloid peptides in brain of an animal without affecting soluble APP level; administering test compound to an ovariectomized non-human animal; beta.17-estradiol reversed ovx-associated levels; Alzheimer's |
| 04/10/2008 | CA2664842A1 Arginine derivatives with np-i antagonistic activity |
| 04/09/2008 | EP1908751A1 N-hydroxy benzamides with antitumour activity |
| 04/09/2008 | EP1594867B1 Phenylacetamides and their use as glucokinase modulators |
| 04/09/2008 | CN101157683A Sulfatase inhibiting agent |
| 04/09/2008 | CN101157682A Method for preparing acetyl thiophene |
| 04/08/2008 | US7355049 Biaryloxymethylarenecarboxylic acids as glycogen synthase activator |
| 04/03/2008 | WO2008037628A1 Sulfonamide derivatives |
| 04/03/2008 | WO2008016883A3 Inhibitors of plasma kallikrein |
| 04/03/2008 | WO2008004190A3 Polymorphic form of duloxetine hydrochloride |
| 04/03/2008 | WO2007098189A3 New crystal forms and pharmaceutical compositions of (+) -r-zileuton |
| 04/03/2008 | WO2007017728A3 Novel heterocyclic compounds |
| 04/03/2008 | US20080081917 Poly(phenoxyalkanoic acid esters) of polyols in which the phenyl rings are substituted with sulfonium salts of thioxanthenes or thioxanthones; for use in surface coating applications, such as printing inks and varnishes |
| 04/03/2008 | US20080081910 5-HT1A receptor antagonists; modulating serotonin levels; central nervous system disorders; antidepressants; synthesis |
| 04/03/2008 | US20080081807 Arylphenyl-substituted cyclic keto-enols |
| 04/03/2008 | US20080079356 Organoelectroluminescent compound and organoelectroluminescent device employing the same |
| 04/03/2008 | CA2664037A1 Sulfonamide derivatives |
| 04/02/2008 | EP1905760A1 Process for production of optically active aminopentane derivative, intermediate in the process and process for production of the intermediate |
| 04/02/2008 | EP1904473A1 Benzoheterocyclylethylcarboxamide derivatives |
| 04/02/2008 | EP1904472A1 Thiophene compounds and thrombopoietin receptor activators |
| 04/02/2008 | EP1904471A1 Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents |
| 04/02/2008 | EP1904443A1 New benzoheterocyclylethylbenzamide derivatives |
| 04/02/2008 | EP1201648B1 Carbamate derivatives and agricultural/horticultural bactericides |
| 04/02/2008 | CN101155795A Method for the production of substituted thiophenesulfonyl isocyanates |
| 04/02/2008 | CN101153036A Organic light-emitting compound and organic light-emitting element comprising the same |
| 04/02/2008 | CN100378106C Process and intermediates for the preparation of the thienopyrrole derivatives |
| 04/02/2008 | CN100378075C Aniline derivative using as phosphodiesterase 4 inhibitor |
| 04/02/2008 | CN100378059C Diastereoselective method of preparing olefins by means of the Horner-Wadsworth-Emmons reaction, comprising the addition of a tris-(polyoxaalkyl)-amine sequestering agent |
| 04/02/2008 | CN100378056C Luminous compounds and labeling reagents using the same |
| 04/01/2008 | US7351841 Heterocyclic compounds and thrombopoietin receptor activators |
| 04/01/2008 | US7351825 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) (MMP) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis |
| 04/01/2008 | US7351735 (3-Amino-6-phenyl-benzofuran-2-yl)-(2,4-dichloro-phenyl)-methanone; antiprolifrative, anticarcinogenic, antitumor agent; lymphomas, sarcomas, and leukemias |
| 04/01/2008 | US7351725 For therapy of immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection |
| 04/01/2008 | US7351719 Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds |
| 04/01/2008 | US7351703 Which modulate the endogenous production of cyclic guanosine monophosphate (cGMP); for therapy and prophylaxis of cardiovascular disorders such as high blood pressure, angina pectoris, cardiac insufficency, thromboses, and/or atherosclerosis |
| 03/27/2008 | WO2008036653A2 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 03/27/2008 | WO2008008660A3 Cyclopentane derivatives as antiglaucoma agents |
| 03/27/2008 | WO2007139984A3 Duloxetine hcl polymorphs |
| 03/27/2008 | WO2007136573A3 Antidiabetic bicyclic compounds |
| 03/27/2008 | WO2007127212A3 Anti-viral agents that activate rnase l |
| 03/27/2008 | US20080076815 Sulfonamide or sulfonimide functional indazole or indole compounds such as N-[3-[2-[2-(3-methylindazol-6-yloxy)ethylamino]-1-hydryoxyethyl]phenyl]methanesulfonamide; diabetes, obesity, hyperlipidemia and urinary incontinence |
| 03/27/2008 | US20080076806 Glycine transporter gene 1 (GlyT-1); psychosis, schizophrenia, dementia; activation of NMDA receptors via GlyT-1 inhibition; N-(([(4-chloro-phenyl)-phenyl-methyl]-carbamoyl)-methyl)-4-fluorobenzamide for example |
| 03/27/2008 | US20080076662 Microencapsulated metal catalyst |
| 03/27/2008 | US20080074753 Compound, Polymer and Optical Component |
| 03/27/2008 | CA2662773A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 03/26/2008 | EP1903036A1 Reactive mesogenic charge transport compounds containing at least two thiophene groups |
| 03/26/2008 | EP1902017A1 Antiviral compounds and methods |
| 03/26/2008 | EP1730108B1 Stereoselective synthesis of vitamin d analogues |
| 03/26/2008 | EP0971878B1 Amine compounds, their production and use as amyloid-beta production inhibitors |
| 03/26/2008 | CN101151257A Process for production of 1-(3-(2-(1-benzothiophen-5-yl)-ethoxy)propyl)azetidin-3-ol or salts thereof |
| 03/26/2008 | CN101151248A 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroayryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity |
| 03/26/2008 | CN101148400A Method for preparing aldehydes and ketones by using oxygen gas to oxidize alcohols |
| 03/26/2008 | CN100376551C Semicarbazone synthesis method |
| 03/25/2008 | USRE40183 7-Substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines |
| 03/25/2008 | US7348428 Triarylamine containing monomers for optoelectronic devices |
| 03/25/2008 | US7348359 Retinoid X receptor modulators |
| 03/25/2008 | US7348328 MCH antagonists for the treatment of obesity |
| 03/25/2008 | US7348125 Optical information recording medium and novel immonium compound |
| 03/20/2008 | WO2008032715A1 Organic semiconductor material, organic semiconductor device using the same, and their production methods |
| 03/20/2008 | WO2008032665A1 Novel phenylacetic acid derivative |
| 03/20/2008 | WO2008031534A1 Insecticidal compounds |
| 03/20/2008 | WO2008031509A1 ISOSERINE DERIVATIVES FOR USE AS COAGULATION FACTOR IXa INHIBITORS |
| 03/20/2008 | WO2008015137A3 Substituted indanyl sulfonamide compounds, their preparation and use as medicaments |
| 03/20/2008 | WO2007113327A3 Fungicide n-cyclopropyl-sulfonylamide derivatives |
| 03/20/2008 | US20080071084 Method for preparing alkyl ethers and aryl ethers |
| 03/20/2008 | US20080071083 Methods for minimizing thioamide impurities |
| 03/20/2008 | US20080070976 Thiophene-2,5-dicarboxylic acid 2-hydroxyamide 5-({1-[4-(4-trifluoromethoxy-benzyloxy)-phenyl]-ethyl}-amide); histone deacetylase inhibitors; anticancer; antiproliferative |
| 03/20/2008 | US20080070974 4-((1E)-2-(((E)-2-fluoro-4-cyanostyrylsulfonyl)methylsulfonyl)vinyl)-3-fluoro-benzonitrile; mitogen activated protein kinase inhibitor; cell growth factor receptor antagonist; angiogenesis inhibitor, antiproliferative and anticarcinogenic agent; neurodegenerative diseases |
| 03/20/2008 | US20080070970 Novel indole derivatives as selective androgen receptor modulators (sarms) |
| 03/20/2008 | US20080070959 Guanylhydrazone compounds, compositions, methods of making and using |
| 03/20/2008 | US20080070956 ATPase inhibitors; Substituted fluorene or benzenerings joined to an alkylene through a sulfone or sulfoxide linkage; without excessive toxicity, irritation, allergic response etc.; sleep dioredrs like excessive sleepiness; Parkinson's disease; Alzheimer's disease; ADD; ADHA; depression, fatigue |
| 03/20/2008 | US20080070911 Ion channel modulating compounds and uses thereof |
| 03/20/2008 | US20080070869 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators |
| 03/20/2008 | US20080069789 N-(2-Thiophen-2-ylethyl)benzene-1,4-diamine; hair dye; very strong and sparingly selective coloration of keratin fibers, light fast, avoiding the degradation of the fibers |
| 03/20/2008 | CA2663544A1 Isoserine derivatives for use as coagulation factor ixa inhibitors |
| 03/20/2008 | CA2663234A1 Novel phenylacetic acid derivative |
| 03/19/2008 | EP1899317A2 Enantiomers of n,n-dimethyl-3-(2-thienyl)-3-hydroxypropanamine borane as intermediates in the synthesis of duloxetine |
| 03/19/2008 | EP1899299A2 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 03/19/2008 | CN101143854A Synthesis method for dibenzoxazole compounds |
| 03/19/2008 | CN100375740C Astaxanthin esters |
| 03/18/2008 | US7345174 Selectively inducing terminal differentiation of neoplastic cells; antiproliferative agents; antineoplastic agents; antitumor agents; melanomes; acute leukemia, multiple myeloma; carcinomas; neuroblastoma; N-t-butoxycarbonyl- omega -methyl - alpha -aminosuberateanilide |
| 03/18/2008 | US7345094 Synergistic; side effect reduction; melanomas; toxicity; 2,5-Dimethoxythiobenzoic Acid N-methylhydrazine; anticancer |
| 03/18/2008 | CA2206125C N-substituted hydrazinophenylsulphonylureas, as herbicides and plant growth regulators |
| 03/13/2008 | WO2008030618A1 Benzo-fused compounds for use in treating metabolic disorders |
| 03/13/2008 | WO2008029306A2 Thiophene derivatives as s1p1/edg1 receptor agonists |
| 03/13/2008 | WO2008028937A1 N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions |
| 03/13/2008 | WO2008008718A3 Cyclopentane derivatives as antiglaucoma agents |
| 03/13/2008 | WO2007148102A3 Crystalline duloxetine hydrochloride |
| 03/13/2008 | WO2007068370A3 Pyrazolyl carboxamides |